Literature DB >> 31005393

Narrowing performance gap between rural and urban hospitals for acute myocardial infarction care.

Fares Alghanem1, John M Clements2.   

Abstract

BACKGROUND: Rural communities experience significant barriers to quality healthcare, including disparities in medical care following acute myocardial infarctions (AMI). This study sought to determine if the population density of the county where Medicare patients were hospitalized following AMI predicted short-term outcomes and to quantify longitudinal changes in hospital performance on quality of care metrics.
METHODS: Hospital-level data was queried from the 2012 and 2018 Centers for Medicare & Medicaid Services archives. Each hospital was classified based on residing county using the National Center for Health Statistics Rural-Urban Continuum Codes (RUCC). Variations and longitudinal changes in risk-adjusted outcomes and quality of care metrics were stratified by RUCC classification and analyzed.
RESULTS: Among the 4798 hospitals identified, rural hospitals had significantly higher risk-adjusted 30-day mortality (rs = 0.095, p < 0.001) and decreased statin prescribed at discharge (rs = -0.066, p = 0.004). Only aspirin (R2 = 0.003, p = 0.024) and statin (R2 = 0.006, p = 0.001) prescribed at discharge were correlated with improved 30-day mortality. Despite these differences, from 2012 to 2018 the performance gap between rural and urban hospitals narrowed for all but one quality of care metric, with concurrent 1.83% [95% CI 1.76-1.90] and 3.37% [95% CI 3.30-3.44] reductions in mortality and hospital readmissions, respectively.
CONCLUSIONS: In the United States, only modest variations currently exist between rural and urban hospitals in the medical care of AMI. Although the performance gap has narrowed, new strategies to improve timely and effective care are necessary to alleviate residual cardiovascular healthcare disparities in rural communities.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute; Infarction; Myocardial; Outcomes; Quality; Rural

Mesh:

Substances:

Year:  2019        PMID: 31005393     DOI: 10.1016/j.ajem.2019.04.030

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Association of Rural Hospital Admissions with Access, Treatment, and Mortality for Patients with Acute Myocardial Infarction in Shanxi, China.

Authors:  Ding Tao; Ya Sun
Journal:  Int J Environ Res Public Health       Date:  2022-05-24       Impact factor: 4.614

2.  Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability.

Authors:  Denis Kibira; Gaby Isabelle Ooms; Hendrika A van den Ham; Juliet Sanyu Namugambe; Tim Reed; Hubert Gm Leufkens; Aukje Mantel-Teeuwisse
Journal:  BMJ Open       Date:  2021-01-07       Impact factor: 2.692

3.  Regional variations in the process of care for patients undergoing percutaneous coronary intervention in Japan.

Authors:  Satoshi Shoji; Kyohei Yamaji; Alexander T Sandhu; Nobuhiro Ikemura; Yasuyuki Shiraishi; Taku Inohara; Paul A Heidenreich; Tetsuya Amano; Yuji Ikari; Shun Kohsaka
Journal:  Lancet Reg Health West Pac       Date:  2022-03-15

4.  Understanding the importance of social determinants and rurality for the long-term outcome after acute myocardial infarction: study protocol for a single-centre cohort study.

Authors:  Benjamin Sasko; Philipp Jaehn; Rhea Müller; Henrike Andresen; Stephan Müters; Christine Holmberg; Oliver Ritter; Nikolaos Pagonas
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

Review 5.  Continuity of Nursing Care in Patients with Coronary Artery Disease: A Systematic Review.

Authors:  Gloria Posadas-Collado; María J Membrive-Jiménez; José L Romero-Béjar; José L Gómez-Urquiza; Luis Albendín-García; Nora Suleiman-Martos; Guillermo A Cañadas-De La Fuente
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.